| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 4.889 | 34.251 | 34.336 | 33.265 | 32.445 | 28.420 | 22.038 |
| Total Income - EUR | - | - | - | 5.252 | 40.469 | 33.612 | 32.910 | 33.481 | 29.023 | 22.896 |
| Total Expenses - EUR | - | - | - | 5.757 | 29.669 | 22.697 | 20.683 | 24.599 | 30.787 | 29.859 |
| Gross Profit/Loss - EUR | - | - | - | -505 | 10.800 | 10.915 | 12.227 | 8.882 | -1.764 | -6.963 |
| Net Profit/Loss - EUR | - | - | - | -577 | 10.469 | 10.381 | 11.970 | 8.654 | -2.023 | -7.181 |
| Employees | - | - | - | 3 | 2 | 1 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Naturustiq S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 135 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 6.109 | 15.313 | 22.978 | 31.909 | 39.831 | 30.269 | 16.314 |
| Inventories | - | - | - | 3.816 | 8.189 | 952 | 1.819 | 2.904 | 4.846 | 9.780 |
| Receivables | - | - | - | 243 | 232 | 3.489 | 1.239 | 2.060 | 3.245 | 0 |
| Cash | - | - | - | 2.050 | 6.892 | 18.536 | 28.850 | 34.868 | 6.005 | 6.534 |
| Shareholders Funds | - | - | - | 1.572 | 12.011 | 22.164 | 29.387 | 38.132 | 28.715 | 13.507 |
| Social Capital | - | - | - | 2.149 | 2.107 | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | - | - | - | 4.672 | 3.302 | 814 | 2.522 | 1.699 | 1.554 | 2.806 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1413 - 1413" | |||||||||
| CAEN Financial Year |
1413
|
|||||||||
Comments - Naturustiq S.r.l.